Synergy Pharmaceuticals Added to the MSCI Global Small Cap Indices

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 30, 2013 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has been upgraded to the MSCI Global Small Cap Indices and deleted from the MSCI Global Micro Cap Indices, effective prior to the market open on Friday, May 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC